Benefits this Solution Provides
![icon-early-phase-01](https://www.valgenesis.com/hs-fs/hubfs/vg-theme/vg-solutions/early-phase-drug/icons/icon-early-phase-01.png?width=150&height=150&name=icon-early-phase-01.png)
Profit From Our Substantial Expertise
Take advantage of our vast experience applying ML in drug discovery and development.
![icon-early-phase-02](https://www.valgenesis.com/hs-fs/hubfs/vg-theme/vg-solutions/early-phase-drug/icons/icon-early-phase-02.png?width=150&height=150&name=icon-early-phase-02.png)
Speed Up Drug Screening and De Novo Design
Apply ML-based quantitative structure-activity relationship (QSAR) and inverse QSAR models.
![icon-early-phase-03](https://www.valgenesis.com/hs-fs/hubfs/vg-theme/vg-solutions/early-phase-drug/icons/icon-early-phase-03.png?width=150&height=150&name=icon-early-phase-03.png)
Accelerate Developability Assessment
Evaluate developability score with ML-based prediction models.
![icon-early-phase-04](https://www.valgenesis.com/hs-fs/hubfs/vg-theme/vg-solutions/early-phase-drug/icons/icon-early-phase-04.png?width=150&height=150&name=icon-early-phase-04.png)
Reduce Costs
Improve the efficiency of in-depth analysis of individual data for favorite candidates.
_________
_________
_________
See how ValGenesis can support your digital transformation.